Domestic pharmaceutical companies at international symposiums

Hanmi Pharm has attracted interests as announcing the clinical trial result of ‘Olita(generic name: olmutinib),’ a targeted therapy drug for lung cancer, at major academia conferences, such as 2014/2015 ASCO(American Society of Clinical Oncology), 2015 ESMO Asia(European Society for Medical Oncology Asia) and 2015 ELCC(European Lung Cancer Conference).

Moreover, the company has borne a fruit ...